What is tdap™?
•
|
The Targeted
Diagnostics Advocacy Program (tdap™) is designed
to extend epidermal growth factor receptor (EGFR)
education and screening to cancer patients and
their physician teams.
|
•
|
The
tdap™ EGFR
kit contains
the necessary materials for specimen submission
including instructions, requisition form, and
shipping materials.
(order kits >)
|
tdap™ Advantage
•
|
TMD performs all
testing in our CAP-accredited, CLIA-certified,
GLP compliant laboratory.
|
•
|
TMD’s physician
services team is available to coordinate
specimen shipping and results reporting between
oncology offices and pathology labs.
|
Test Methodology
•
|
TMD
strictly adheres to the Dako EGFR pharmDx™ kit
guidelines using only the supplied FDA approved
antibodies, reagents, and test procedures
|
•
|
All testing is
performed in a single laboratory facility by a
designated EGFR team to ensure consistency and
reproducibility of the test system.
|
•
|
EGFR pharmDx
testing is performed using Dako automated
immunostainers.
|
•
|
Scoring is
performed according to EGFR pharmDx package
insert reporting guidelines including the
recommended documentation of staining patterns
and intensities.
|
Turnaround Time
Results are reported electronically to all
physicians listed on the requisition form within
48 hours of specimen receipt.
|
|
|
